The US Supreme Court has ruled that patents rights in a product are exhausted after sale in the US or internationally, in a decision that included some strongly-worded pushback of the Federal Circuit. Pharmaceutical companies could be particularly affected because of their downstream licensing models
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
Louis-Pierre Gravelle discusses why he didn’t want to be part of the newly acquired Bereskin & Parr and the opportunities he’s eyeing at his new home, Dipchand
Innovation and expertise will be showcased again in Munich in November at the fourteenth edition of IP Service World as the future of intellectual property management comes under the spotlight